Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …

In the summer of 2016, delegates from the German Society of Cardiology (DGK), the
German Respiratory Society (DGP), and the German Society of Pediatric Cardiology (DGPK) …

Pulmonary arterial hypertension (PAH) is a rare disease that can be caused by (likely)
pathogenic germline genomic variants. In addition to the most prevalent disease gene …

Background A genetic predisposition can lead to the rare disease pulmonary arterial
hypertension (PAH). Most mutations have been identified in the gene BMPR2 in heritable …

The integrated stress response (ISR) is a conserved mechanism by which eukaryotic cells
remodel gene expression to adapt to intrinsic and extrinsic stressors rapidly and reversibly …

Erratum: 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension:
Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the …

The pathogenesis of idiopathic and heritable forms of pulmonary arterial hypertension is still
not completely understood, even though several causative genes have been proposed, so …

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and death
worldwide. Peroxynitrite, formed from nitric oxide, which is derived from inducible nitric oxide …

Pulmonary arterial hypertension (PAH) is a rare cardiovascular disease with very high
mortality rate. The currently available therapeutic strategies, which improve symptoms …

Pulmonary arterial hypertension is a very infrequent disease, with a variable etiology and
clinical expressivity, making sometimes the clinical diagnosis a challenge. Current …